NCT07589595 · Interventional trial
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Overall registry status Recruiting
Phase 2
Conditions Amyloid, Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies
Delaware Valley sites
- Pennsylvania Hospital · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory